205 results on '"Pilatus U"'
Search Results
2. 1H- and 13C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer’s disease
3. Frequency drift in MR spectroscopy at 3T
4. Neuroradiological Viewpoint on the Diagnostics of Space-Occupying Brain Lesions
5. Combined 1H and 31P MR spectroscopic imaging: impaired energy metabolism in severe carotid stenosis and changes upon treatment
6. Diagnostic impact of proton MR-spectroscopy versus image-guided stereotactic biopsy
7. Proton magnetic resonance spectroscopy in childhood brainstem lesions
8. An unusual intraventricular haemangiopericytoma: MRI and spectroscopy
9. Proton MR Spectroscopy of Neurometabolites in Hepatic Encephalopathy During L-Ornithine-L-Aspartate Treatment–Results of a Pilot Study
10. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions
11. Lower Lactate Levels and Lower Intracellular pH in Patients with IDH-Mutant versus Wild-Type Gliomas
12. Sex-associated differences in mitochondrial function in human peripheral blood mononuclear cells (PBMCs) and brain
13. Brain energy metabolism in early MSA-P: A phosphorus and proton magnetic resonance spectroscopy study
14. Effects of aerobic exercise on brain metabolism and grey matter volume in older adults: results of the randomised controlled SMART trial
15. Diffusion Tensor Imaging reveals microstructural brain changes in patients with Progressive supranuclear palsy
16. Effects of coenzyme Q10 in progressive supranuclear palsy
17. Die kombinierte 31P- und 1H-MR-Spektroskopie im 3T Hochfeldscanner zeigt mesostriatale Energiestoffwechselstörungen bei idiopathischem Parkinson-Syndrom
18. P06.05 Myoinositol as a predictive baseline biomarker for overall survival of patients with recurrent glioblastoma treated with Bevacizumab: A 1H-magnetic resonance spectroscopy study.
19. P07.05 Intracellular pH measured by 31P MR-Spectroscopy predicts site of progression in recurrent glioblastoma under antiangiogenic therapy with bevacizumab
20. P07.06 Does IDH1 R132H Mutation alter phospholipid metabolism in glioma? A 31 P-MRS in vivo study
21. Intratumoral bioavailability and changes in Phosphoethanolamin-MRI of the solubilised natural compound curcumin in glioblastoma patients
22. Choline containing compounds in the discrimination between high- and low-grade gliomas - comparison of maximum and mean values
23. Prognostischer Wert der 1H-Spektroskopie bei unbehandelten niedriggradigen Gliomen
24. P668: Lack of a relationship between MRS-GABA-levels, LTD-like plasticity and motor learning in the human cortex
25. Choline containing compounds in the discrimination between high- and low-grade gliomas - comparison of maximum and mean values
26. Prognostic value of 1H-spectroscopy in untreated low-grade gliomas
27. Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival
28. Metabolic Changes in Patients with Aneurysmal Subarachnoid Hemorrhage Apart from Perfusion Deficits: Neuronal Mitochondrial Injury?
29. Abnormalities in MRI during non convulsive status mimicking recurrence of glioma
30. Objectification and Quantification of the Cognitive Impairment from an Existing HIV Infection or HIV Encephalopathy Using Magnetic Resonance Spectroscopy
31. GBA-associated PD: Neurodegeneration, altered membrane metabolism, and lack of energy failure
32. Cutoff Value of Choline Concentration Reliably Reveals High-Grade Brain Tumors among Other Contrast-Enhancing Brain Lesions
33. Cutoff Value of Choline Concentration Reliably Reveals High-Grade Brain Tumors among Other Contrast-Enhancing Brain Lesions
34. Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging study
35. Die kombinierte 31P- und 1H-MR-Spektroskopie im 3T Hochfeldscanner zeigt mesostriatale Energiestoffwechselstörungen bei idiopathischem Parkinson-Syndrom
36. Diffusion Tensor Imaging reveals microstructural brain changes in patients with Progressive supranuclear palsy
37. Combined 1H and 31P MR spectroscopic imaging: impaired energy metabolism in severe carotid stenosis and changes upon treatment
38. Effects of coenzyme Q10 in progressive supranuclear palsy
39. Spektroskopie bei Hirntumoren
40. H- and C-NMR spectroscopy of Thy-1-APP mice brain extracts indicates metabolic changes in Alzheimer's disease.
41. Proton magnetic resonance spectroscopy in childhood brainstem lesions
42. Einsatz von 3Tesla-Geräten in der neuroradiologischen Forschung
43. 3 Tesla in der Neuroradiologie – Fortschritt oder Spielerei
44. Diffusion-Weighted MRI of the Spinal Cord in Spinal Stroke
45. Grundlagen und klinische Anwendung der MR-Spektroskopie des Gehirns
46. Na+-Dependent Ca2+ Transport Modulates the Secretory Response to the Fcϵ Receptor Stimulus of Mast Cells
47. Cellular SCFA content of colonic epithelial cells (HT29-C1) is dependent on regulation of intracellular and extracellular pH
48. Magnetic resonance microscopy and spectroscopy reveal kinetics of cryoprotectant permeation in a multicompartmental biological system.
49. Na+ and Ca2+ Gradients across the Membrane Modulate the Secretory Response of Mast Cells
50. Objectification and quantification of the cognitive impairment from an existing HIV infection or HIV encephalopathy using magnetic resonance spectroscopy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.